메뉴 건너뛰기




Volumn 2, Issue 6, 2009, Pages

Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: A case report

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; DEPAKIN CHRONO; FELBAMATE; LAMOTRIGINE; PARATHYROID HORMONE; UNCLASSIFIED DRUG; VALPROIC ACID; VIGABATRIN; VITAMIN D;

EID: 77953449190     PISSN: 17571626     EISSN: None     Source Type: Journal    
DOI: 10.4076/1757-1626-2-7394     Document Type: Article
Times cited : (40)

References (12)
  • 1
    • 3543063973 scopus 로고    scopus 로고
    • Bone disease in epilepsy
    • Pack AM: Bone disease in epilepsy. Curr Neurol Neurosci Rep 2004, 4:329-334.
    • (2004) Curr Neurol Neurosci Rep , vol.4 , pp. 329-334
    • Pack, A.M.1
  • 2
    • 1642566108 scopus 로고    scopus 로고
    • Pathophysiology of bone loss in patients receiving anticonvulsant therapy
    • Fitzpatrick LA: Pathophysiology of bone loss in patients receiving anticonvulsant therapy. Epilepsy Behavioural 2004, 5: S3-S15.
    • (2004) Epilepsy Behavioural , vol.5
    • Fitzpatrick, L.A.1
  • 3
    • 33747876227 scopus 로고    scopus 로고
    • Adverse effects of antiepileptic drugs on bone mineral density
    • Babaygit A, Dirik E, Bober E, Cakmakci H: Adverse effects of antiepileptic drugs on bone mineral density. Pediatr Neurol 2006, 35:177-181.
    • (2006) Pediatr Neurol , vol.35 , pp. 177-181
    • Babaygit, A.1    Dirik, E.2    Bober, E.3    Cakmakci, H.4
  • 4
    • 4644245150 scopus 로고    scopus 로고
    • Effect of carbamazepine and valproate on bone mineral density
    • Ecevit C, Aydoǧan A, Kavakli T, Altinöz S: Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol 2004, 31:279-282.
    • (2004) Pediatr Neurol , vol.31 , pp. 279-282
    • Ecevit, C.1    Aydoǧan, A.2    Kavakli, T.3    Altinöz, S.4
  • 5
    • 0035859862 scopus 로고    scopus 로고
    • Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy
    • Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K: Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurol 2001, 57:445-449.
    • (2001) Neurol , vol.57 , pp. 445-449
    • Sato, Y.1    Kondo, I.2    Ishida, S.3    Motooka, H.4    Takayama, K.5    Tomita, Y.6    Maeda, H.7    Satoh, K.8
  • 7
    • 0022515632 scopus 로고
    • A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy
    • Gough H, Goggin T, Bissessar A, Baker M, Crowley M, Callaghan N: A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. QJ Med 1986, 59:569-577.
    • (1986) QJ Med , vol.59 , pp. 569-577
    • Gough, H.1    Goggin, T.2    Bissessar, A.3    Baker, M.4    Crowley, M.5    Callaghan, N.6
  • 10
    • 34548839635 scopus 로고    scopus 로고
    • Bone mineral density with lamotrigine monotherapy for epilepsy
    • Sheth RD, Hermann BP: Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol 2007, 37:250-254.
    • (2007) Pediatr Neurol , vol.37 , pp. 250-254
    • Sheth, R.D.1    Hermann, B.P.2
  • 12
    • 0035653766 scopus 로고    scopus 로고
    • Analysis of the muscoloskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine
    • Rieger-Wettengl G, Tutlewski B, Stabrey A, Rauch F, Herkenrath P, Schauseil-Zipf U, Schoenau E: Analysis of the muscoloskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine. Pediatrics 2001, 108:E107.
    • (2001) Pediatrics , vol.108
    • Rieger-Wettengl, G.1    Tutlewski, B.2    Stabrey, A.3    Rauch, F.4    Herkenrath, P.5    Schauseil-Zipf, U.6    Schoenau, E.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.